Clinical trial
S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant…
NCT00003723 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00003723 |
|---|---|
| Title | S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery |
| Official title | Phase II Study of Gemcitabine and Cisplatin in Unresectable Malignant Mesothelioma |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Malignant Mesothelioma |
| Intervention type | Drug |
| Interventions | gemcitabine hydrochloride |
| Enrollment | 57 |
| Start date | Feb 1, 1999 |
| Primary completion | Jun 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jun 24, 2004 |
| Last update posted | Oct 8, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: